Nuvation Bio Inc.
NUVB
$2.23
-$0.13-5.51%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.67% | -19.98% | 91.09% | -3,026.64% | -7.29% |
| Total Depreciation and Amortization | 41.55% | 35.19% | -33.61% | 320.69% | 5.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -22.03% | 93.79% | -98.84% | 11,738.75% | 2,428.47% |
| Change in Net Operating Assets | 140.90% | -235.65% | 181.19% | -32.89% | -219.85% |
| Cash from Operations | 7.94% | -48.95% | 16.72% | -137.70% | -4.48% |
| Capital Expenditure | -653.85% | 108.78% | -- | 100.00% | -107.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.63% | 77.18% | 34.53% | 187.40% | -77.18% |
| Cash from Investing | 4.66% | 77.81% | -15.05% | 354.43% | -77.26% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | 93.00% | -137.94% | 49.26% | -- | -- |
| Issuance of Common Stock | -6.64% | -30.60% | -17.94% | 9,590.48% | -82.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 160.89% | 41.48% | -155.97% | 12,985.71% | -82.50% |
| Foreign Exchange rate Adjustments | -86.48% | 250.54% | -1,051.28% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 115.47% | 233.84% | -1,788.44% | 97.24% | -144.59% |